Pfizer Net Change in Short-Term Investments (Under 3 Months) increased by 149.2% to $583.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 34.4%, from $889.00M to $583.00M. Over 2 years (FY 2021 to FY 2024), Net Change in Short-Term Investments (Under 3 Months) shows a downward trend with a -37.7% CAGR.
Reflects the company's active management of near-cash liquidity and short-term treasury positioning.
This metric tracks the net cash flow from short-term financial instruments with original maturities of three months or l...
Varies by company; some firms include these in cash equivalents, while others report them separately.
cf_pfe_short_term_investments_under_three_months| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$491.00M | $6.65B | $936.00M | -$3.41B | $6.56B | $7.72B | -$4.67B | $15.88B | -$5.12B | -$11.28B | $1.19B | -$4.73B | $889.00M | -$487.00M | $3.85B | -$1.18B | $583.00M |
| QoQ Change | — | >999% | -85.9% | -464.2% | +292.5% | +17.7% | -160.4% | +440.5% | -132.2% | -120.4% | +110.5% | -498.1% | +118.8% | -154.8% | +891.0% | -130.7% | +149.2% |
| YoY Change | — | — | — | — | >999% | +16.2% | -36.8% | +142.0% | -166.2% | — | +125.4% | -129.8% | +117.4% | +95.7% | +224.5% | +74.9% | -34.4% |